Price
$12.61
Decreased by -1.71%
Dollar Volume
8.80 M
ADR%
8.18
Earnings Report Date (estimate)
Jan 9, 23 (N/A)
Market Cap.
917.84 M
Shares Float
65.62 M
Shares Outstanding
72.79 M
Beta
1.36
Price / Earnings
-6.54
BPR
148.42
20D Range
6.83 13.62
50D Range
6.83 13.62
200D Range
4.61 14.12
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Jan 9, 23 -0.56
Decreased by -280.65%
-0.62
Increased by +9.68%
Oct 6, 22 -0.66
Increased by +31.96%
-0.72
Increased by +8.33%
Jun 30, 22 -4.92
Decreased by -485.71%
-0.67
Decreased by -634.33%
Apr 28, 22 -0.51
Decreased by -131.82%
-0.36
Decreased by -41.67%
Jan 10, 22 0.31
Increased by +196.88%
-0.74
Increased by +141.89%
Oct 7, 21 -0.97
Decreased by -106.38%
-0.56
Decreased by -73.21%
Jul 8, 21 -0.84
Increased by +50.30%
-0.37
Decreased by -127.03%
May 5, 21 -0.22
Increased by +96.28%
-0.10
Decreased by -120.00%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Nov 30, 22 90.95 M
Increased by +8.98%
-39.87 M
Decreased by -277.19%
Decreased by -43.84%
Decreased by -262.58%
Aug 31, 22 87.64 M
Increased by +19.59%
-46.52 M
Increased by +25.40%
Decreased by -53.08%
Increased by +37.62%
May 31, 22 85.53 M
Increased by +43.68%
-342.82 M
Decreased by -603.85%
Decreased by -400.83%
Decreased by -389.87%
Feb 28, 22 93.76 M
Increased by +58.29%
-34.56 M
Decreased by -631.19%
Decreased by -36.86%
Decreased by -361.94%
Nov 30, 21 83.45 M
Increased by +117.07%
22.50 M
Increased by +235.60%
Increased by +26.97%
Increased by +162.47%
Aug 31, 21 73.29 M
Increased by +99.22%
-62.36 M
Decreased by -305.73%
Decreased by -85.09%
Decreased by -103.66%
May 31, 21 59.53 M
Increased by +65.84%
-48.71 M
Decreased by -248.90%
Decreased by -81.82%
Decreased by -110.38%
Feb 28, 21 59.23 M
Increased by +33.28%
-4.73 M
Decreased by -120.94%
Decreased by -7.98%
Decreased by -65.77%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.